|
|
View Clinical Trial (Medical Research Study)
|
Omega-3 Fatty Acids and Post Traumatic Stress Disorder (PTSD) - NCT00644423-27705 (Clinical Trial 212143)
Permalink: http://www.ClinicalConnection.com/exp/ExpandedPatientViewStudy212143.aspx
|
** Please review additional "Nearby Studies" on right ----->
|
|
 |
 |
|
| City: |
|
Durham |
|
State:
|
|
NC |
| Zip Code: |
|
27705 |
| Conditions: |
|
Posttraumatic Stress Disorder |
| Purpose: |
|
An increasing literature shows that omega-3 fatty acids provide numerous health benefits,
including a variety of psychiatric symptoms and disorders including stress, anxiety,
cognitive impairment, mood disorders (major depression and bipolar disorder) and
schizophrenia. Omega-3 fatty acids may additionally represent a promising treatment
strategy in patients with PTSD. Moreover, given its beneficial cardiovascular effects,
adjunctive omega-3 fatty acids may also benefit the general health status of these veterans,
who frequently present with a variety of comorbid medical disorders.
|
| Study summary: |
|
See brief summary |
| Criteria: |
|
Inclusion Criteria:
1. Veterans 18-65 years of age, any ethnic group, either sex.
2. Ability to participate fully in the informed consent process.
3. Current diagnosis of PTSD .
4. No anticipated need to alter medications for the 10-week duration of the study.
Exclusion Criteria:
1. Serious unstable medical illness, history of traumatic brain injury with loss of
consciousness greater than 30 minutes, or history of cerebrovascular accident,
prostate or breast cancer.
2. Current active suicidal and/or homicidal ideation, intent or plan.
3. Use of aspirin, warfarin or other anticoagulant therapy, as omega-3 fatty acids may
increase bleeding time. Other concomitant medications for medical conditions will be
addressed on a case-by-case base and determined if exclusionary.
4. Regular use of omega-3 fatty acid supplementation within the last 3 months (cod liver
oil, other fish oil, flaxseed).
5. Regular consumption of more than one serving of fatty fish per week.
6. Substance dependence within the last 4 weeks (other than nicotine dependence).
7. Current DSM-IV diagnosis of bipolar disorder, schizophrenia or other psychotic
disorder, or cognitive disorder due to a general medical condition other than TBI.
8. Female patients who are pregnant or breast-feeding.
9. Known allergy to study medication. |
|
|
|
| Study is available at: |
|
Durham VA Medical Center
Durham, NC 27705
United States
Primary Contact:
Victoria Payne, MD, MS
Email: payne@biac.duke.edu
Phone: (919)286-0411 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 15, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinical trials are medical research studies designed to test the safety and/or
effectiveness of new drugs, devices, or treatments in humans. These studies are
conducted worldwide for a range of conditions and illnesses. Learn more about
clinical research and participating in a study at
About Clinical Trials.
|
|
|
|
|
|
|
|